The unexpected G0/G1 cell cycle status of mobilized hematopoietic stem cells from peripheral blood

Blood

Volumn 89, Issue 2, 1997, Pages 465-472

  Uchida, Nobuko ^a   He, Dongping ^a   Friera, Annabelle M ^a   Reitsma, Michael ^a   Sasaki, Dennis ^a   Chen, Ben ^a   Tsukamoto, Ann ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ANIMAL CELL; ARTICLE; BLOOD; BONE MARROW; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031015915     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.2.465     Document Type: Article

References (34)

1. Bender JG, To LB, Williams S, Schwartzberg LS: Defining a therapeutic dose of peripheral blood stem cells. J Hematother 1:329, 1992
2. Juttner C, To L: Autologous peripheral blood stem cell transplantation: Potential advantages, practical considerations and initial clinical results, in Atkinson K (ed): Clinical Bone Marrow Transplantation: A Reference Text Book. Cambridge, UK, Cambridge, 1994, p 142
3. Bensinger W, Weaver C, Appelbaum F, Rowley S, Demirer T, Sanders J, Storb R, Buckner C: Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 85:1655, 1995
4. Korbling M, Przepiorka D, Huh YO, Engel H, van Besien K, Giralt S, Andersson B, Kleine HD, Seong D, Deisseroth AB, Andreeff M, Champlin R: Allogenic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 85:1659, 1995
5. Schmitz N, Dreger P, Suttorp M, Rohwedder E, Haferlach T, Loffler H, Hunter A, Russell N: Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 85:1666, 1995
6. To LB, Roberts MM, Haylock DN, Dyson PG, Brantford AL, Thorp D, Ho JQ, Dart GW, Horvath N, Davy ML, Olweny CLM, Abdi E, Juttner CA: Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 9:277, 1992
7. Zimmerman TM, Lee WJ, Bender JG, Mick R, Williams SF: Quantitative CD34 analysis may be used to guide peripheral blood stem cell harvests. Bone Marrow Transplant 15:439, 1995
8. Negrin RS, Kusnierz-Glaz CR, Still BJ, Schriber JR, Chao NJ, Long GD, Hoyle C, Hu WW, Horning SJ, Brown BW, Blume KG, Strober S: Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma. Blood 85:3334, 1995
9. Watt S, Visser J: Recent advances in the growth and isolation of primitive human haemopoietic progenitor cells. Cell Prolif 25:263, 1992
10. Morrison SI, Uchida N, Weissman IL: The biology of hematopoietic stem cells. Annu Rev Cell Biol 11:35, 1995
11. Spangrude GJ, Heimfeld S, Weissman IL: Purification and characterization of mouse hematopoietic stem cells. Science 241:58, 1988
12. Ikuta K, Weissman IL: Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. Proc Natl Acad Sci USA 89:1502, 1992
13. Morrison SJ, Weissman IL: The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity 1:661, 1994
14. Fleming WH, Alpern EJ, Uchida N, Ikuta K, Weissman IL: Steel factor influences the distribution and activity of murine hematopoietic stem cells in vivo. Proc Natl Acad Sci USA 90:3760, 1993
15. Baum CM, Weissman IL, Tsukamoto AS, Buckle A, Peault B: Isolation of a candidate human hematopoietic stem cell population. Proc Natl Acad Sci USA 89:2804, 1992
16. Craig W, Kay R, Cutler R, Lansdorp PM: Expression of Thy-1 on human hematopoietic progenitor cells. J Exp Med 177:1331, 1993
17. - subpopulation from mobilized peripheral blood. Blood 85:368, 1995
18. Sasaki DT, Tichenor EH, Lopez F, Combs J, Uchida N, Smith CR, Stokdijk W, Vardanega M, Buckle AM, Chen B, Tushinski R, Tsukamoto AS, Hoffman R: Development of a clinically applicable high-speed flow cytometer for the isolation of transplantable human hematopoietic stem cells. J Hematother 4:503, 1995
19. Fleming WH, Alpern EJ, Uchida N, Ikuta K, Spangrude GJ, Weissman IL: Functional heterogenity is associated with the cell cycle status of murine hematopoietic stem cells. J Cell Biol 122:897, 1993
20. Uchida N, Jerabek L, Weissman IL: Searching for hematopoietic stem cells. II. The heterogeneity of Thy-1.1(lo)Lin(-/lo)Sca-1+ mouse hematopoietic stem cells separated by counterflow centrifugal elutriation. Exp Hematol 24:649, 1996
21. Morse HC III, Shen F-W, Hammerling U: Genetic nomenclature for loci controlling mouse lymphocyte antigens. Immunogenetics 25:71, 1987
22. Molineux G, Pojda Z, Dexter TM: A comparison of hematopoiesis in normal and spectomized mice treated with granulocyte colony-stimulating factor. Blood 75:563, 1990
23. Molineux G, Pojda Z, Hampson IN, Lord BI, Dexter TM: Transplantation potential of peripheral blood stem cells induced by granulocyte colony-stimulating factor. Blood 76:2153, 1990
24. Briddell RA, Hartley CA, Smith KA, McNiece IK: Recombinant rat stem cell factor synergizes with recombinant human granulocyte colony-stimulating factor in vivo in mice to mobilize peripheral blood progenitor cells that have enhanced repopulating potential. Blood 82:1720, 1993
25. Neben S, Marcus K, Mauch P: Mobilization of hematopoietic stem and progenitor cell subpopulations from the marrow to the blood of mice following cyclophosphamide and/or granulocyte colony-stimulating factor. Blood 81:1960, 1993
26. Uchida N, He D, Friera A, Ford B, Hoffman R, Tsukamoto A: Variation in the kinetics of mouse stem cell mobilization following treatment using various mobilization regiments; engraftment activity of murine MPB HSC. Blood 86:113a, 1995 (abstr. suppl 1)
27. Sasaki DT, Dumas S, Engleman E: Discrimination of viable and non-viable cells using propidium iodide in two color immunofluorescence. Cytometry 8:443, 1987
28. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC: Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 183:1797, 1996
29. Bodine DM, Seidel NE, Gale MS, Niehuis AW, Orlic D: Efficient retrovirus transduction of mouse pluripotent hematopoietic stem cell mobilized into the peripheral blood by treatment with granulocyte colony-stimulating factor and stem cell factor. Blood 84:1482, 1994
30. Wolf NS, Trentin JJ: Hemopoietic colony studies. V. Effect of hemopoietic organ stroma on differentiation of pluripotent stem cells. J Exp Med 127:205, 1968
31. Till J, McCulloch E: A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res 14:213, 1961
32. + cells in Thy-1 expression and cell cycle status in nonhuman primates mobilized or not mobilized with granulocyte colony-stimulating factor and/or stem cell factor. Blood 87:1644, 1996
33. Roberts AW, Metcalf D: Noncycling state of peripheral blood progenitor cells mobilized by granulocyte colony-stimulating factor and other cytokines. Blood 86:1600, 1995
34. Siegert W, Serke S: Cytokine mobilized blood CD34-expressing cells are not cycling. Bone Marrow Transplant 17:467, 1996